Literature DB >> 10395471

High-throughput nuclear magnetic resonance-based screening.

P J Hajduk1, T Gerfin, J M Boehlen, M Häberli, D Marek, S W Fesik.   

Abstract

A high-throughput screening strategy is described that involves the acquisition of two-dimensional 15N/1H correlation spectra in less than 10 min on 50 microM protein samples using cryogenic NMR probe technology. By screening at these concentrations, small organic molecules can be tested in mixtures of 100, which dramatically increases the throughput of the NMR-based assay. Using this strategy, libraries of more than 200 000 compounds can be tested in less than 1 month. There are many advantages of high-throughput NMR-based screening compared to conventional assays, such as the ability to identify high-affinity ligands for protein targets with no known function. This suggests that the method will be extremely useful for screening the large number of targets derived from genomics research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395471     DOI: 10.1021/jm9901475

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  31 in total

1.  Automation of NMR measurements and data evaluation for systematically screening interactions of small molecules with target proteins.

Authors:  A Ross; G Schlotterbeck; W Klaus; H Senn
Journal:  J Biomol NMR       Date:  2000-02       Impact factor: 2.835

2.  An approach for high-throughput structure determination of proteins by NMR spectroscopy.

Authors:  A Medek; E T Olejniczak; R P Meadows; S W Fesik
Journal:  J Biomol NMR       Date:  2000-11       Impact factor: 2.835

3.  Determination of molecular alignment tensors without backbone resonance assignment: Aid to rapid analysis of protein-protein interactions.

Authors:  Markus Zweckstetter
Journal:  J Biomol NMR       Date:  2003-09       Impact factor: 2.835

4.  Two WXXF-based motifs in NECAPs define the specificity of accessory protein binding to AP-1 and AP-2.

Authors:  Brigitte Ritter; Alexei Yu Denisov; Jacynthe Philie; Christophe Deprez; Elaine C Tung; Kalle Gehring; Peter S McPherson
Journal:  EMBO J       Date:  2004-09-09       Impact factor: 11.598

5.  NMR screening and crystal quality of bacterially expressed prokaryotic and eukaryotic proteins in a structural genomics pipeline.

Authors:  Rebecca Page; Wolfgang Peti; Ian A Wilson; Raymond C Stevens; Kurt Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

6.  Unsupervised guided docking of covalently bound ligands.

Authors:  Xavier Fradera; Jasmit Kaur; Jordi Mestres
Journal:  J Comput Aided Mol Des       Date:  2004-10       Impact factor: 3.686

7.  Determining the optimal size of small molecule mixtures for high throughput NMR screening.

Authors:  Kelly A Mercier; Robert Powers
Journal:  J Biomol NMR       Date:  2005-03       Impact factor: 2.835

Review 8.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

9.  Drug screening strategy for human membrane proteins: from NMR protein backbone structure to in silica- and NMR-screened hits.

Authors:  Steffen Lindert; Innokentiy Maslennikov; Ellis J C Chiu; Levi C Pierce; J Andrew McCammon; Senyon Choe
Journal:  Biochem Biophys Res Commun       Date:  2014-02-10       Impact factor: 3.575

Review 10.  Finally, An Apoptosis-Targeting Therapeutic for Cancer.

Authors:  Carlo M Croce; John C Reed
Journal:  Cancer Res       Date:  2016-09-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.